-+ 0.00%
-+ 0.00%
-+ 0.00%

TELOMIR PHARMACEUTICALS SUBMITS IND TO FDA FOR TELOMIR-1 (TELOMIR-ZN) IN ADVANCED AND METASTATIC TRIPLE-NEGATIVE BREAST CANCER

Reuters·03/31/2026 11:07:44

Please log in to view news